Enteral administration of the protease inhibitor gabexate mesilate preserves vascular function in experimental trauma/hemorrhagic shock.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 06 2023
Historique:
received: 16 03 2023
accepted: 27 05 2023
medline: 26 6 2023
pubmed: 23 6 2023
entrez: 22 6 2023
Statut: epublish

Résumé

Preserving vascular function is crucial for preventing multiorgan failure and death in ischemic and low-pressure states such as trauma/hemorrhagic shock (T/HS). It has recently been reported that inhibiting circulating proteases released from the bowel to the circulation during T/HS may preserve vascular function and improve outcomes following T/HS. This study aimed to evaluate the role of the serine protease inhibitor gabexate mesilate (GM) in preserving vascular function during T/HS when given enterally. We studied the vascular reactivity of mesenteric arteries from male Wistar rats treated with enteral GM (10 mg/kg) (GM-treated, n = 6) or control (Shock-control, n = 6) following (T/HS) using pressure myography. Concentration-response curves of endothelial-dependent and endothelial-independent agonists (e.g., acetylcholine, sodium nitroprusside) ranging from 10

Identifiants

pubmed: 37349360
doi: 10.1038/s41598-023-36021-7
pii: 10.1038/s41598-023-36021-7
pmc: PMC10287748
doi:

Substances chimiques

Gabexate 4V7M9137X9
Serine Proteinase Inhibitors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

10148

Informations de copyright

© 2023. The Author(s).

Références

J Surg Res. 2005 May 15;125(2):128-36
pubmed: 15854664
Proc Natl Acad Sci U S A. 2000 Feb 15;97(4):1772-7
pubmed: 10677533
J Cell Physiol. 1994 Apr;159(1):121-30
pubmed: 8138580
Integr Biol (Camb). 2014 Mar;6(3):338-47
pubmed: 24480876
Am J Physiol Heart Circ Physiol. 2016 Jul 1;311(1):H157-67
pubmed: 27199133
J Trauma. 2005 Aug;59(2):284-90
pubmed: 16294066
Int J Mol Sci. 2021 Jul 06;22(14):
pubmed: 34298897
J Trauma Acute Care Surg. 2016 Aug;81(2):358-65
pubmed: 27027557
Drug Discov Today Dis Models. 2011 Spring;8(1):57-62
pubmed: 22059089
FEMS Immunol Med Microbiol. 2008 Dec;54(3):309-18
pubmed: 19049643
Shock. 2012 Aug;38(3):262-7
pubmed: 22576000
J Vasc Res. 1993 Mar-Apr;30(2):73-9
pubmed: 8504198
Curr Opin Crit Care. 2016 Apr;22(2):152-60
pubmed: 26808138
Crit Care Explor. 2021 Jul 06;3(7):e0469
pubmed: 34250499
Nephrol Dial Transplant. 2001 Jun;16(6):1189-97
pubmed: 11390719
Sci Rep. 2020 Dec 11;10(1):21826
pubmed: 33311525
J Trauma Acute Care Surg. 2017 Aug;83(2):263-270
pubmed: 28422915
Am J Physiol Regul Integr Comp Physiol. 2007 Sep;293(3):R1215-21
pubmed: 17553850
Front Physiol. 2019 Feb 21;10:99
pubmed: 30846942
World J Crit Care Med. 2015 Nov 04;4(4):287-95
pubmed: 26557479
J Investig Med. 2002 Jan;50(1):19-24
pubmed: 11820226
Shock. 2005 May;23(5):411-6
pubmed: 15834306
J Hypertens. 2001 Mar;19(3):415-20
pubmed: 11288811
J Intern Med. 2016 Jul;280(1):97-113
pubmed: 26749537
Circulation. 2001 Mar 6;103(9):1238-44
pubmed: 11238267
Br J Anaesth. 2012 Mar;108(3):384-94
pubmed: 22290457
Shock. 2003 Mar;19(3):208-14
pubmed: 12630519
J Head Trauma Rehabil. 2020 Sep/Oct;35(5):317-323
pubmed: 32881765
Am J Transl Res. 2022 Oct 15;14(10):7391-7402
pubmed: 36398214
J Biol Chem. 2005 Oct 14;280(41):34441-6
pubmed: 16087677
Eur J Immunol. 1991 Nov;21(11):2887-90
pubmed: 1936126
Circ Res. 2003 Nov 14;93(10):e136-42
pubmed: 14563712
Biochem Biophys Res Commun. 2007 Mar 30;355(1):228-33
pubmed: 17291452
Vascul Pharmacol. 2018 Jan;100:26-33
pubmed: 28919014
J Biol Chem. 1997 Jun 6;272(23):14713-20
pubmed: 9169435
Microcirculation. 2000 Jun;7(3):183-92
pubmed: 10901497
Crit Care Med. 2004 May;32(5 Suppl):S271-9
pubmed: 15118530
Shock. 2000;13(4):267-73
pubmed: 10774614
Eur J Trauma Emerg Surg. 2022 Jun;48(3):1579-1588
pubmed: 33483765
Cardiovasc Res. 2010 Jul 15;87(2):300-10
pubmed: 20462866
PLoS One. 2014 Oct 08;9(10):e109596
pubmed: 25295599
PLoS One. 2018 Aug 23;13(8):e0202526
pubmed: 30138400
Ann Surg. 2011 Aug;254(2):194-200
pubmed: 21772125
Anaesthesia. 2014 Jul;69(7):777-84
pubmed: 24773303
Shock. 2016 Mar;45(3):259-70
pubmed: 26871664
Circ Shock. 1992 Mar;36(3):238-41
pubmed: 1611708
Shock. 2002 Dec;18(6):567-73
pubmed: 12462567
Circulation. 2002 Dec 10;106(24):3073-8
pubmed: 12473554
Shock. 2001 May;15(5):329-43
pubmed: 11336191
Am J Physiol. 1993 Sep;265(3 Pt 2):H973-9
pubmed: 8214134
Cells. 2022 Jun 19;11(12):
pubmed: 35741101
Shock. 2002 Mar;17(3):205-9
pubmed: 11900339
Curr Vasc Pharmacol. 2016;14(2):187-95
pubmed: 26638794
J Vis Exp. 2015 Jul 06;(101):e50997
pubmed: 26168315

Auteurs

Nathalia J D Moreira (N)

Instituto do Coração, Hospital das ClínicasFaculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil. nathaliajuocys@hotmail.com.

Fernando Dos Santos (F)

Department of Anesthesiology and Critical Care, University of California, San Diego, La Jolla, CA, USA.

Joyce B Li (JB)

Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.

Federico Aletti (F)

Universidade Federal de São Paulo, São José dos Campos, Brazil.

Maria Claudia C Irigoyen (MCC)

Instituto do Coração, Hospital das ClínicasFaculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

Erik B Kistler (EB)

Department of Anesthesiology and Critical Care, University of California, San Diego, La Jolla, CA, USA.
Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH